108 results
P
adults in England
I/C
benzodiazepine or Z-drug (BZRA) deprescribing, gradual tapering alone
O
successful discontinuation in the short and long term, and withdrawal symptoms
P
NSCLC patients
I/C
Xiao-ai-ping injection (XAPI) + platinum-based chemotherapy, platinum-based chemotherapy alone
O
objective tumor response rate (ORR), Karnofsky performance scores (KPS), occurrence of grade 3/4 leukopenia, anemia, thrombocytopenia, nausea and vomiting, immune function (CD8)
P
Lewy body disease (LBD), Alzheimer's disease (AD), frontotemporal lobar degeneration (FTLD), healthy elderly individuals
I/C
orexin-A levels in cerebrospinal fluid (CSF), patients with LBD vs. patients with AD, patients with LBD vs. patients with FTLD, LBD patients with excessive daytime sleepiness (EDS) vs. healthy elderly individuals
O
mean orexin-A CSF levels, standard mean difference (SMD), 95% confidence interval (CI), Z-score, P-value
P
prolactinoma, hyperprolactinemia
I/C
prolactin excess, control group
O
BMD Z-scores, bone mineral density, bone mineral content, fragility fractures
P
insomnia
I/C
orexin receptor antagonists (ORAs), benzodiazepine-like drugs (Z-drugs), melatonin receptor agonists (MRAs), placebo
O
sleep latency (SL), awake time after sleep onset (WASO), total sleep time (TST), sleep efficiency (SE), sleep quality (SQ), adverse events (AED)
P
Mustapha AD, Salame Z, Chrcanovic BR
I/C
Smoking, Dental Implants, No smoking, Dental implants in non-smokers
O
Clinical outcomes
P
Yu X, Xu R, Zhang Z, Yang Y, Deng F
I/C
extra-short implants (≤ 6 mm), longer implants (≥ 8 mm)
O
bone augmentation
P
school-aged children
I/C
school nutrition interventions, multi-component interventions, physical activity interventions, nutrition education, overweight/obesity reduction interventions, prevention interventions
O
changes in body mass index (BMI), changes in body mass index z score (BAZ)
P
spinal surgery patients
I/C
low-protein malnutrition, normal nutritional status
O
postoperative complications, postoperative readmission, postoperative death
P
elderly
I/C
Shouhui Tongbian Capsules (SHTB), control group
O
total effective rate, clinical symptom score, gastrointestinal peptide index, adverse reactions, recurrence rate